financetom
Business
financetom
/
Business
/
US SEC again extends deadline for private funds to supply enhanced data on risk 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US SEC again extends deadline for private funds to supply enhanced data on risk 
Sep 17, 2025 8:58 AM

WASHINGTON (Reuters) -A divided U.S. Securities and Exchange Commission on Wednesday voted 3-1 to extend for a second time the deadline for private investment funds to comply with Biden-era regulations requiring enhanced disclosures.

Along with the Commodity Futures Trading Commission, the SEC last year approved rules requiring private funds and investment advisers to tell regulators confidentially about their exposures to investments, counterparties, currencies, countries and specific industries to help regulators spot the build up of risk in the $24 trillion private investment sector.

Private funds and advisers will now have until Oct 1, 2026 to comply with the rule, giving the SEC time to develop possible changes to make the regulatiosn less burdensome, officials said at a public meeting.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
La Rosa Holdings Sells Majority Stake in LR Kissimmee Realty LLC for $0.5 Million, Eliminates Non-Core Expense
La Rosa Holdings Sells Majority Stake in LR Kissimmee Realty LLC for $0.5 Million, Eliminates Non-Core Expense
Mar 11, 2026
Celebration, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (“La Rosa” or the “Company”), a real estate and PropTech enterprise, today announced the sale of its 51% ownership interest in Horeb Kissimmee Realty LLC (“LR Kissimmee”) for $0.5 million. The transaction represents the divestiture of a non-core office operation and marks a significant step in strengthening the...
Stoke Therapeutics Initiates Early-Stage Study for Genetic Vision Loss Treatment
Stoke Therapeutics Initiates Early-Stage Study for Genetic Vision Loss Treatment
Mar 11, 2026
09:12 AM EST, 02/11/2026 (MT Newswires) -- Stoke Therapeutics ( STOK ) said Wednesday that the first patient has received a dose in an early-stage trial of STK-002 for the treatment of Autosomal Dominant Optic Atrophy, an inherited vision loss condition. The open-label study's primary objective will be to evaluate the safety and tolerability of the investigational medicine in patients...
GCI Liberty's Q4 Revenue Declines
GCI Liberty's Q4 Revenue Declines
Mar 11, 2026
09:12 AM EST, 02/11/2026 (MT Newswires) -- GCI Liberty ( GLIBA ) reported revenue for Q4 ended Dec. 31 of $262 million, compared with $263 million a year earlier. One analyst surveyed by FactSet expected $264 million. The company was spun off from Liberty Broadband (LBRDA, LBRDK) in July 2025. ...
Sector Update: Consumer Stocks Mixed Premarket Wednesday
Sector Update: Consumer Stocks Mixed Premarket Wednesday
Mar 11, 2026
09:11 AM EST, 02/11/2026 (MT Newswires) -- Consumer stocks were mixed premarket Wednesday, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) 0.3% lower and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) up 0.4%. Shopify ( SHOP ) shares were up more than 12% after the company posted Q4 net income and revenue that topped...
Copyright 2023-2026 - www.financetom.com All Rights Reserved